0001209191-18-025436.txt : 20180418 0001209191-18-025436.hdr.sgml : 20180418 20180418173125 ACCESSION NUMBER: 0001209191-18-025436 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180416 FILED AS OF DATE: 20180418 DATE AS OF CHANGE: 20180418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SPECTOR STEVEN W CENTRAL INDEX KEY: 0001170362 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31161 FILM NUMBER: 18761950 MAIL ADDRESS: STREET 1: ARENA PHARMACEUTICALS INC STREET 2: 6166 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARENA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001080709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232908305 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6154 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-453-7200 MAIL ADDRESS: STREET 1: 6154 NANCY RIDGE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-04-16 0 0001080709 ARENA PHARMACEUTICALS INC ARNA 0001170362 SPECTOR STEVEN W C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 0 1 0 0 EVP, General Counsel & Sec Common Stock 2018-04-16 4 M 0 15001 17.90 A 34691 D Common Stock 2018-04-16 4 M 0 15000 18.10 A 49691 D Common Stock 2018-04-16 4 S 0 20901 34.3264 D 28790 D Common Stock 2018-04-16 4 S 0 7700 34.9957 D 21090 D Common Stock 2018-04-16 4 S 0 1400 35.8107 D 19690 D Employee Stock Option (right to buy) 17.90 2018-04-16 4 M 0 15001 0.00 D 2022-12-15 Common Stock 15001 14999 D Employee Stock Option (right to buy) 18.10 2018-04-16 4 M 0 15000 0.00 D 2022-03-19 Common Stock 15000 34530 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.77 to $34.76, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4 to this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.77 to $35.63, inclusive. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.80 to $35.84, inclusive. The options vest in four equal annual installments and are exercisable once vested. The first and second installments became exercisable on December 15, 2016 and 2017, and the third and fourth installments vest on December 15, 2018 and 2019. The options vested in four equal annual installments on March 19, 2013, 2014, 2015 and 2016, and were immediately exercisable once vested. Steven W. Spector 2018-04-18